Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Prenetics Group ( (PRE) ) has shared an announcement.
On December 30, 2025, Prenetics Global Limited announced a major capital allocation shift, confirming that it stopped its daily Bitcoin purchases on December 4 and will no longer deploy capital into additional cryptocurrency acquisitions. The company will retain its current holding of 510 Bitcoin as a treasury reserve asset while redirecting all new and existing capital exclusively toward scaling IM8, its high-growth consumer health brand, which has already exceeded $100 million in annualized recurring revenue and is projected to generate $180–$200 million in revenue in fiscal 2026. Backed by a debt-free balance sheet with more than $70 million in cash and cash equivalents, the move consolidates Prenetics’ strategic focus around IM8’s rapid global expansion, product innovation, and brand-building efforts, aiming to enhance long-term shareholder value and sharpen its positioning in the competitive wellness and longevity sector.
The most recent analyst rating on (PRE) stock is a Hold with a $14.00 price target. To see the full list of analyst forecasts on Prenetics Group stock, see the PRE Stock Forecast page.
Spark’s Take on PRE Stock
According to Spark, TipRanks’ AI Analyst, PRE is a Neutral.
The overall stock score of 51 reflects significant profitability challenges and valuation concerns, despite positive technical trends. The company’s strong equity base and low leverage provide some financial stability, but improvements in cash flow and profitability are essential for a more favorable outlook.
To see Spark’s full report on PRE stock, click here.
More about Prenetics Group
Prenetics Global Limited (Nasdaq: PRE) is a health sciences company focused on consumer health and longevity, primarily through its flagship premium nutrition brand IM8. Co-founded with David Beckham and backed by an international team of scientists, IM8 offers science-based supplement products such as its Daily Ultimate Essentials all-in-one powder, targeting the fast-growing global wellness and performance market. IM8 has rapidly become one of the fastest-growing brands in the supplement industry, surpassing $100 million in annualized recurring revenue within 11 months of launch.
Average Trading Volume: 154,314
Technical Sentiment Signal: Hold
Current Market Cap: $238.1M
Learn more about PRE stock on TipRanks’ Stock Analysis page.